CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Computed tomography (CT) and magnetic resonance (MR) imaging play critical roles in the diagnosis and staging of hepatocellular carcinoma (HCC). The first article of this two-part review discusses key concepts of HCC development, growth, and spread, emphasizing those features with imaging correlates and hence most relevant to radiologists; state-of-the-art CT and MR imaging technique with extracellular and hepatobiliary contrast agents; and the imaging appearance of precursor nodules that eventually may transform into overt HCC.

[1]  Young Kon Kim,et al.  Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤ 2.0 cm) in patients with hepatitis-induced liver cirrhosis , 2013, Acta radiologica.

[2]  Elaine M. Caoili,et al.  Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. , 2013, Radiology.

[3]  M. Reiser,et al.  Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate , 2012, Acta radiologica.

[4]  Rajagopal N. Aravalli,et al.  Cellular and molecular mechanisms of hepatocellular carcinoma: an update , 2012, Archives of Toxicology.

[5]  N. Hosten,et al.  Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. , 2012, Radiology.

[6]  B. Corcioni,et al.  Which is the best MRI marker of malignancy for atypical cirrhotic nodules: Hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd‐EOB‐DTPA administration , 2012, Journal of magnetic resonance imaging : JMRI.

[7]  R. Brody,et al.  An inflammatory proposal for hepatocarcinogenesis , 2012, Hepatology.

[8]  W. Palmer,et al.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.

[9]  J. Bruix,et al.  Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. , 2012, Journal of hepatology.

[10]  E. Brunt,et al.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. , 2012, Journal of hepatology.

[11]  A. Tanimoto,et al.  Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[12]  R. Vaughan,et al.  The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. , 2012, Human Pathology.

[13]  N. Rofsky,et al.  Hepatobiliary MR imaging with gadolinium‐based contrast agents , 2012, Journal of magnetic resonance imaging : JMRI.

[14]  T. Tamada,et al.  Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver. , 2011, European journal of radiology.

[15]  M. Sherman,et al.  Indeterminate 1‐2‐cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none? , 2011, Hepatology.

[16]  N. Toyota,et al.  Clinical Significance of the Transitional Phase at Gadoxetate Disodium–Enhanced Hepatic MRI for the Diagnosis of Hepatocellular Carcinoma: Preliminary Results , 2011, Journal of computer assisted tomography.

[17]  Osamu Matsui,et al.  Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression , 2011, European Radiology.

[18]  C. Verslype,et al.  Molecular classification of hepatocellular carcinoma anno 2011. , 2011, European journal of cancer.

[19]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[20]  M. Fiorentino,et al.  OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation , 2011, Virchows Archiv.

[21]  Y. N. Park Update on precursor and early lesions of hepatocellular carcinomas. , 2011, Archives of pathology & laboratory medicine.

[22]  O. Matsui,et al.  The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging , 2011, European Radiology.

[23]  K. McGlynn,et al.  The global epidemiology of hepatocellular carcinoma: present and future. , 2011, Clinics in liver disease.

[24]  R. Gish,et al.  Hepatocellular carcinoma: molecular and genomic guideline for the clinician. , 2011, Clinics in liver disease.

[25]  N. Nishida,et al.  Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review , 2011, Current genomics.

[26]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[27]  O. Matsui,et al.  Effect of change in transporter expression on gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging during hepatocarcinogenesis in rats , 2011, Journal of gastroenterology and hepatology.

[28]  Myeong-Jin Kim,et al.  Hepatocarcinogenesis: imaging-pathologic correlation , 2011, Abdominal Imaging.

[29]  C. Bartolozzi,et al.  Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR , 2011, Abdominal Imaging.

[30]  O. Matsui,et al.  Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging. , 2010, Radiology.

[31]  Osamu Matsui,et al.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.

[32]  Yuan Ji,et al.  Contribution of Diffusion-Weighted Magnetic Resonance Imaging in the Characterization of Hepatocellular Carcinomas and Dysplastic Nodules in Cirrhotic Liver , 2010, Journal of computer assisted tomography.

[33]  Jessica Zucman-Rossi,et al.  Molecular classification of hepatocellular carcinoma. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[34]  M. Kudo Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress , 2010, Oncology.

[35]  Tonsok Kim,et al.  Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. , 2010, Radiology.

[36]  Masahiro Okada,et al.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow , 2010, European Radiology.

[37]  K. Suh,et al.  Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[38]  J. Marrero,et al.  Recent advances in the treatment of hepatocellular carcinoma , 2010, Current opinion in gastroenterology.

[39]  Jeong Min Lee,et al.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma , 2010, Hepatology international.

[40]  R. Freeman,et al.  Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[41]  P. Robinson,et al.  Enhancement of liver parenchyma after injection of hepatocyte‐specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine , 2010, Journal of magnetic resonance imaging : JMRI.

[42]  T. Roskams,et al.  Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. , 2010, Seminars in liver disease.

[43]  K. Hegenscheid,et al.  Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol. , 2009, AJR. American journal of roentgenology.

[44]  T. Murakami,et al.  Consensus report of the 2nd International Forum for Liver MRI , 2009, European Radiology.

[45]  C. Loddenkemper,et al.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. , 2009, AJR. American journal of roentgenology.

[46]  J. Bruix,et al.  Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma , 2009, Hepatology.

[47]  O. Matsui,et al.  Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. , 2009, Radiology.

[48]  Y. Maehara,et al.  Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in Japan , 2009, Annals of Surgical Oncology.

[49]  J. Marrero,et al.  Modern diagnosis and management of hepatocellular carcinoma. , 2009, Clinics in liver disease.

[50]  X. Hao,et al.  Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. , 2009, Surgical oncology.

[51]  H. Honda,et al.  Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. , 2009, Radiology.

[52]  Michiie Sakamoto,et al.  Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.

[53]  Y. Maehara,et al.  Extracapsular Penetration is a New Prognostic Factor in Human Hepatocellular Carcinoma , 2008, The American journal of surgical pathology.

[54]  D. Mitchell,et al.  Single breath‐hold multiarterial dynamic MRI of the liver at 3T using a 3D fat‐suppressed keyhole technique , 2008, Journal of magnetic resonance imaging : JMRI.

[55]  F. Trevisani,et al.  Recent advances in the natural history of hepatocellular carcinoma. , 2008, Carcinogenesis.

[56]  J. Willatt,et al.  MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. , 2008, Radiology.

[57]  D. Aguirre,et al.  Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[58]  J. Bruix,et al.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.

[59]  M. Sakamoto Pathology of early hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[60]  K. Gurusamy Trace Element Concentration in Primary Liver Cancers—A Systematic Review , 2007, Biological Trace Element Research.

[61]  H. Honda,et al.  Poorly Versus Moderately Differentiated Hepatocellular Carcinoma: Vascularity Assessment by Computed Tomographic Hepatic Angiography in Correlation With Histologically Counted Number of Unpaired Arteries , 2007, Journal of computer assisted tomography.

[62]  Derek Y. Chiang,et al.  Genomics and signaling pathways in hepatocellular carcinoma. , 2007, Seminars in liver disease.

[63]  K. Jhaveri,et al.  Value of the Unenhanced Phase for Detection of Hepatocellular Carcinomas 3 cm or Less When Performing Multiphase Computed Tomography in Patients With Cirrhosis , 2007, Journal of computer assisted tomography.

[64]  Lorella Pascolo,et al.  Molecular Determinants in the Transport of a Bile Acid-Derived Diagnostic Agent in Tumoral and Nontumoral Cell Lines of Human Liver , 2006, Journal of Pharmacology and Experimental Therapeutics.

[65]  E. Lesaffre,et al.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.

[66]  Myeong-Jin Kim,et al.  Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. , 2006, AJR. American journal of roentgenology.

[67]  Katsuyoshi Ito Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. , 2006, European journal of radiology.

[68]  Won J. Lee,et al.  Encapsulated hepatocellular carcinoma: CT-pathologic correlations , 2006, European Radiology.

[69]  Yoshiyuki Suzuki,et al.  Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis , 2006, Cancer.

[70]  J. Mintorovitch,et al.  Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.

[71]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[72]  Maximilian F Reiser,et al.  Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. , 2005, Radiology.

[73]  Carlo Catalano,et al.  Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. , 2005, Radiology.

[74]  M. Kojiro,et al.  Histopathology of liver cancers. , 2005, Best practice & research. Clinical gastroenterology.

[75]  K. McGlynn,et al.  Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.

[76]  G. Krinsky,et al.  Iron‐containing nodules of cirrhosis , 2004, NMR in biomedicine.

[77]  T. Murakami,et al.  Multidetector Row CT and MR Imaging in Diagnosing Hepatocellular Carcinoma , 2004, Intervirology.

[78]  Josep Fuster,et al.  The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[79]  K. McGlynn,et al.  The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.

[80]  W. Jarnagin,et al.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma. , 2003, Journal of the American College of Surgeons.

[81]  W. Coleman,et al.  Mechanisms of human hepatocarcinogenesis. , 2003, Current molecular medicine.

[82]  Masatoshi Tanaka,et al.  Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[83]  U. Schmiedl,et al.  Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre–liver transplant patients: radiologic–histopathologic correlation of explanted livers , 2003, Abdominal Imaging.

[84]  G. Israel,et al.  Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. , 2003, AJR. American journal of roentgenology.

[85]  H. Ueno,et al.  Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features , 2002, Cancer.

[86]  O. Matsui,et al.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.

[87]  Hiroto Nakajima,et al.  Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? , 2002, AJR. American journal of roentgenology.

[88]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[89]  T. Yamanaka,et al.  Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence? , 2002, Oncology reports.

[90]  J. H. Lim,et al.  Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. , 2002, AJR. American journal of roentgenology.

[91]  V. Lorusso,et al.  Pharmacokinetics and Safety of Gadobenate Dimeglumine (Multihance) in Subjects With Impaired Liver Function , 2002, Investigative radiology.

[92]  K. Takeshita,et al.  Effect of Superparamagnetic Iron Oxide-Enhanced MRI of the Liver With Hepatocellular Carcinoma and Hyperplastic Nodule , 2002, Journal of computer assisted tomography.

[93]  B. I. Choi,et al.  Dysplastic nodules in liver cirrhosis: imaging , 2002, Abdominal Imaging.

[94]  L. Donoso,et al.  Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis. , 2002, Seminars in ultrasound, CT, and MR.

[95]  M S Peterson,et al.  From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[96]  T. Roskams,et al.  Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis , 2001, Histopathology.

[97]  G. Jacobs,et al.  An early lesion in hepatic carcinogenesis: Loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36‐p34 region , 2001, Hepatology.

[98]  M. Uemura,et al.  The formation of capsule and septum in human hepatocellular carcinoma , 2001, Virchows Archiv.

[99]  M. Nalesnik,et al.  Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. , 2000, AJR. American journal of roentgenology.

[100]  N. Rofsky,et al.  Siderotic Nodules at MR Imaging: Regenerative or Dysplastic? , 2000, Journal of computer assisted tomography.

[101]  M. Kojiro,et al.  Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. , 2000, Journal of hepatology.

[102]  J. Svensson,et al.  Image artifacts due to a time‐varying contrast medium concentration in 3D contrast‐enhanced MRA , 1999, Journal of magnetic resonance imaging : JMRI.

[103]  H. Honda,et al.  Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. , 1999, AJR. American journal of roentgenology.

[104]  K. Ohtomo,et al.  Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: Results from phase II and phase III clinical trials in Japan , 1999, Journal of magnetic resonance imaging : JMRI.

[105]  D. Mitchell,et al.  Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. , 1999, Radiology.

[106]  S. Swan,et al.  Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. , 1999, Investigative radiology.

[107]  R. Manfredi,et al.  Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis , 1998, Journal of magnetic resonance imaging : JMRI.

[108]  Y. N. Park,et al.  Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. , 1998, The American journal of surgical pathology.

[109]  T. Nabika,et al.  Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver , 1998, Hepatology.

[110]  K. Okuda Hepatocellular carcinoma: Clinicopathological aspects , 1997, Journal of gastroenterology and hepatology.

[111]  N. Rofsky,et al.  Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. , 1996, Radiology.

[112]  N. Theise Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. , 1996, Gastroenterology.

[113]  K. Batts,et al.  Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. , 1996, Journal of computer assisted tomography.

[114]  N. Theise,et al.  Macroregenerative (Dysplastic) Nodules and Hepatocarcinogenesis: Theoretical and Clinical Considerations , 1995, Seminars in liver disease.

[115]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[116]  M. Sentís,et al.  Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. , 1995, Radiology.

[117]  T. Aihara,et al.  Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. , 1994, Gastroenterology.

[118]  M. Kanematsu,et al.  Extracapsular Invasion of Small Hepatocellular Carcinoma: MR and CT Findings , 1994, Journal of computer assisted tomography.

[119]  M. Kojiro,et al.  Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells , 1993, Hepatology.

[120]  T. Murakami,et al.  CT and MRI of Siderotic Regenerating Nodules in Hepatic Cirrhosis , 1992, Journal of computer assisted tomography.

[121]  S. Fan,et al.  Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases , 1992, Cancer.

[122]  O. Matsui,et al.  Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. , 1992, Radiology.

[123]  K. Shirabe,et al.  Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses , 1991, Hepatology.

[124]  M. Makuuchi,et al.  Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma , 1990, The Lancet.

[125]  T. Terada,et al.  Iron‐accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies , 1990, Cancer.

[126]  M. Kojiro,et al.  Hepatocellular carcinoma presenting as intrabile duct tumor growth. A clinicopathologic study of 24 cases , 1982, Cancer.

[127]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[128]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[129]  V. Mazzaferro,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, European journal of cancer.

[130]  Jun Cui,et al.  Small intestinal vascular malformation bleeding: diagnosis by double-balloon enteroscopy combined with abdominal contrast-enhanced CT examination , 2011, Abdominal Imaging.

[131]  E. Merkle,et al.  Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. , 2010, AJR. American journal of roentgenology.

[132]  O. Nakashima,et al.  Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins , 1995, Hepatology.

[133]  T. Roskams,et al.  Early hepatocellular carcinoma and dysplastic nodules. , 2005, Seminars in liver disease.

[134]  A. Ba-Ssalamah,et al.  Multidetektor-CT (MDCT) der Leber , 2004, Der Radiologe.

[135]  T. Murakami,et al.  Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. , 2002, Archives of surgery.

[136]  O. Matsui,et al.  Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. , 1998, Radiology.

[137]  N M Rofsky,et al.  Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. , 1997, Radiology.

[138]  T. Winter,et al.  CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. , 1995, AJR. American journal of roentgenology.